期刊文献+

HIF-1α基因RNA干扰质粒在胃癌细胞中的构建与鉴定

Construction of a vector carrying a small hairpin RNA targeting the HIF-1α gene and its expression in gastric cancer cells
下载PDF
导出
摘要 目的:构建转录因子HIF-1α表达的RNA干扰(RNA interference,RNAi)质粒,为研究HIF-1α参与的细胞信号通路及以HIF-1α为靶点的基因治疗提供稳定转染细胞的RNAi.方法:选取HIF-1α基因的19nt特异性序列,设计针对HIF-1α的shRNA序列,应用基因重组技术克隆到pSilencer1.0-U6表达载体中,利用EcoRⅠ和ApaⅠ双酶切和DNA测序鉴定重组克隆.低氧条件下,将包含HIF-1α基因RNAi序列的重组载体转染人胃癌细胞SGC-7901,转染48h后,收集细胞裂解液,Western blotting分析低氧条件下对照组与转染组HIF-1α蛋白的表达水平.结果:双酶切证实shRNA插入pSilencer1.0-U6质粒,DNA测序证实插入的序列正确;HIF-1α基因RNAi质粒转染胃癌细胞SGC-7901成功;Western blotting结果显示与空质粒对照组比转染组细胞HIF-1α表达下调.结论:成功构建人HIF-1α基因RNAi质粒,为研究HIF-1α参与的细胞信号通路提供了稳定转染细胞的干扰质粒.同时,阻断HIF-1α的信号通路将为肿瘤基因治疗提供一个较好的靶点,研究结果为以HIF-1α为靶向的基因治疗提供了有利工具. AIM: To construct a plasmid carrying a small hairpin RNA (shRNA) targeting the HIF1α gene and to observe its expression in gastric cancer SGC-7901 cells. METHODS: SHIF-1α-specific shRNA sequence was designed, synthesized and cloned into the expression vector pSilencer 1.0-U6. The recombi- nants were identified by double digestion with EcoR I + Apa I and DNA sequencing, and thentransfected into SGC-7901 cells under hypoxia. Forty-eight hours after transfection, HIF1α expression was detected by Western blotting. RESULTS: Restriction enzyme digestion and DNA sequencing confirmed that the shRNA was correctly inserted into the plasmid pSilenc- er 1.0-U6. The recombinant plasmid carrying the shRNA targeting HIF1α was successfully transfected into SGC-7901 cells. Western blot analysis suggested that HIF1α expression was knocked down in transfected cells compared to control cells. CONCLUSION: A plasmid carrying a shRNA tar- geting HIF1α has been constructed successfully, and SGC-7901 cells stably transfected with this re- combinant vector have been obtained. These will offer favorable tools for studying HIF1α-targeted gene therapy.
出处 《世界华人消化杂志》 CAS 北大核心 2012年第24期2254-2258,共5页 World Chinese Journal of Digestology
基金 国家自然科学基金青年基金资助项目 No.31101003~~
关键词 载体 低氧诱导因子1Α RNA干扰 胃癌 Vector Hypoxia-inducible factor1α RNAi Gastric cancer
  • 相关文献

参考文献19

  • 1Thomlinson RH, Gray LH. The histological struc- ture of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955; 9: 539-549.
  • 2Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for can- cer therapy. Cancer Res 1998; 58:1408-1416.
  • 3Wang GL, Semenza GL. Purification and charac- terization of hypoxia-inducible factor 1. J Biol C]zem 1995; 270:1230-1237.
  • 4Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmaco12006; 70:1469-1480.
  • 5Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Ma- her ER, Ratcliffe PJ. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen- dependent proteolysis. Nature 1999; 399:271-275.
  • 6Ivan M, Kaelin WG. The von Hippel-Lindau tumor suppressor protein. Curr Opin Genet Dev 2001; 11:27-34.
  • 7Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG. HI- Falpha targeted for VHL-mediated destruction byproline hydroxylation: implications for 02 sensing. Science 2001; 292:464-468.
  • 8Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wil- son MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxyl- ation. Cell 2001; 107:43-54.
  • 9Page EL, Robitaille GA, Pouyss6gur J, Richard DE. Induction of hypoxia-inducible factor-lalpha by transcriptional and translational mechanisms. J Biol Chem 2002; 277:48403-48409.
  • 10Huang LE, Gu J, Schau M, Bunn HF. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiqui- tin-proteasome pathway. Proc Natl Acad Sci U S A 1998; 95:7987-7992.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部